| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
1 Baker Heart Research Institute, Melbourne, Victoria, Australia 8008; and 2 Commissariat à l'Energie Atomique, Département d'Ingénierie et d'Etudes des Protéines, Direction des Sciences du Vivant, CE-Saclay 91191, Gif-sur-Yvette Cedex, France
The closely related metalloendopeptidases EC 3.4.24.15 (EP24.15; thimet oligopeptidase) and 24.16 (EP24.16; neurolysin) cleave a number of vasoactive peptides such as bradykinin and neurotensin in vitro. We have previously shown that hypotensive responses to bradykinin are potentiated by an inhibitor of EP24.15 and EP24.16 (26), suggesting a role for one or both enzymes in bradykinin metabolism in vivo. In this study, we have used selective inhibitors that can distinguish between EP24.15 and EP24.16 to determine their activity in cultured endothelial cells (the transformed human umbilical vein endothelial hybrid cell line EA.hy926 or ovine aortic endothelial cells). Endopeptidase activity was assessed using a specific quenched fluorescent substrate [7-methoxycoumarin-4-acetyl-Pro-Leu-Gly-D-Lys(2,4-dinitrophenyl)], as well as the peptide substrates bradykinin and neurotensin (assessed by high-performance liquid chromatography with mass spectroscopic detection). Our results indicate that both peptidases are present in endothelial cells; however, EP24.16 contributes significantly more to substrate cleavage by both cytosolic and membrane preparations, as well as intact cells, than EP24.15. These findings, when coupled with previous observations in vivo, suggest that EP24.16 activity in vascular endothelial cells may play an important role in the degradation of bradykinin and/or other peptides in the circulation.
peptidase; bradykinin; inhibitor; endothelium
This article has been cited by other articles:
|
|
 |
|
  E. B. Oliveira, L. L. Souza, D. O. Sivieri Jr, L. B. Bispo-da-Silva, H. J. V. Pereira, C. M. Costa-Neto, M. V. Sousa, and M. C. O. Salgado Carboxypeptidase B and other kininases of the rat coronary and mesenteric arterial bed perfusates Am J Physiol Heart Circ Physiol, December 1, 2007; 293(6): H3550 - H3557. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. O. Sivieri Jr, L. B. Bispo-da-Silva, E. B. Oliveira, A. C. Resende, and M. C. O. Salgado Potentiation of Bradykinin Effect by Angiotensin-Converting Enzyme Inhibition Does Not Correlate With Angiotensin-Converting Enzyme Activity in the Rat Mesenteric Arteries Hypertension, July 1, 2007; 50(1): 110 - 115. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. J. Cotter, N. v. O. Sweeney, P. M. Coen, Y. A. Birney, M. J. Glucksman, P. A. Cahill, and P. M. Cummins Regulation of Endopeptidases EC3.4.24.15 and EC3.4.24.16 in Vascular Endothelial Cells by Cyclic Strain: Role of Gi Protein Signaling Arterioscler Thromb Vasc Biol, March 1, 2004; 24(3): 457 - 463. [Abstract] [Full Text]
|
|
|
|
|
|
R. A. Skidgel, F. Alhenc-Gelas, and W. B. Campbell Regulation of Cardiovascular Signaling by Kinins and Products of Similar Converting Enzyme Systems: Prologue: Kinins and related systems. New life for old discoveries Am J Physiol Heart Circ Physiol, June 1, 2003; 284(6): H1886 - H1891. [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |
